AstraZeneca Newark Transformation
Newark, Delaware, United States
Lendlease managed AstraZeneca's (AZ) multi-phased Newark Facility Transformation (NFT) project in Newark, Delaware consisting of the construction of a new oral solid dosage (OSD) formulation suite, and renovations and upgrades to the facility's packaging lines, warehouse and support areas.
AstraZeneca Newark Transformation
- Client
- AstraZeneca Pharmaceuticals LP
- Location
- Newark, Delaware, United States
- Completion
- 2017
- Area
- 120,000 square feet
- Assignments
- Construction Management, Cost Plus
- Architect
- CRB
Project outcome
All work was performed while the facility remains fully operational. In March 2016, the Lendlease NFT project team, was awarded a 'Gold Star Safety' at AstraZeneca's Global Engineering's North America Safety awards ceremony.